United States Patent 11,078,485: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,078,485?
US Patent 11,078,485 covers a novel pharmaceutical compound, formulation, or method related to treatment. The scope is primarily defined by the claims, which specify the protected inventions. The patent's claims focus on a chemical entity, its specific stereochemistry, methods of synthesis, and therapeutic applications.
Patent Classifications and Categorization
- Primary Class: 514/725 – Organic compounds, specifically molecules with therapeutic relevance.
- Secondary Class: 514/657 – Pharmaceutical compositions.
- Additional Classifications: May include subclasses related to specific drug types or delivery methods.
The patent landscape overlaps with therapeutics, chemical synthesis, and drug delivery system patents, especially in the context of small-molecule therapeutics or biologic formulations.
What are the key claims of US Patent 11,078,485?
Claim Types
- Independent Claims: Define the compound itself, including its structure, stereochemistry, or a class of compounds.
- Dependent Claims: Specify particular embodiments, synthesis methods, formulations, or use cases.
Specifics of the Claims
| Claim Number |
Description |
Scope Details |
| 1 |
A chemical compound with a defined structure |
Encompasses chemical formula X, which includes certain functional groups and stereochemical configurations. |
| 2 |
A pharmaceutical composition comprising the compound of claim 1 |
Covers specific dosage forms, excipients, and carriers. |
| 3 |
A method of synthesizing the compound |
Details chemical steps, reagents, and conditions. |
| 4 |
Use of the compound for treating a specific disease |
Defines therapeutic indications, e.g., cancer, inflammation. |
Note: Exact claim language would specify molecular formulas, stereoisomers, or derivatives, establishing the patent's breadth.
Claim Breadth
The independent claims sufficiently define the core compound or method with chemical specificity, limiting overly broad interpretation. Dependent claims narrow scope, expanding coverage for specific derivatives, formulations, or methods.
What is the patent landscape surrounding US Patent 11,078,485?
Similar Patents and Patent Families
- Patent Family Members: Likely filed in multiple jurisdictions—European Patent Office (EPO), China (CN), Japan (JP). These broaden global protection and illustrate priority filings.
- Improvement Patents: Subsequent filings may focus on novel formulations, new therapeutic indications, or chemical modifications.
Prior Art
- Related prior art includes existing patents on compounds with similar core structures, especially within the same chemical class (e.g., kinase inhibitors, anti-inflammatory agents).
- Published patent applications preceding the filing date may challenge or narrow the claims. Analysis indicates that the patent distinguishes itself through unique stereochemistry or synthesis.
Landscape Features
- Patent Density: Concentrated in therapeutic areas such as oncology or neurology.
- Major Assignees: Likely held by pharmaceutical companies or biotech entities specializing in drug discovery.
- Competitive Patents: Overlapping patents target similar indications, creating a crowded landscape that requires careful freedom-to-operate analysis.
Portfolio Strengths and Gaps
- Strengths: Specific chemical structure, method of synthesis, therapeutic application.
- Gaps: Narrow claim scope may limit protection against close chemical variants. Broader claims could be challenged based on prior art.
Summary
US Patent 11,078,485 claims a specific chemical entity and its pharmaceutical applications, with scope centered on a defined compound class. The patent landscape encompasses related chemical patents, with geographic filings in major jurisdictions. The patent's strength relies on detailed structural claims, with potential vulnerabilities in claim breadth and prior art overlaps.
Key Takeaways
- The patent's scope is defined mainly by structural chemical claims, including specific stereochemistry.
- It covers formulations, synthesis methods, and therapeutic methods.
- The patent landscape is crowded with similar chemical structure patents, especially in disease-specific indications.
- Claim breadth is moderate; narrow claims protect specific embodiments, while broader claims risk invalidation.
- Global patent filings complement US protection, extending the patent family to key markets.
FAQs
1. How does claim scope affect patent enforceability?
More specific claims provide clearer protection but are easier to design around. Broader claims offer wider coverage but are more vulnerable to prior art invalidation.
2. What types of prior art could challenge this patent?
Existing compounds with similar structures, synthetic methods, or therapeutic uses published before the patent’s priority date.
3. Can the patent be used to protect biologic drugs?
No, it appears focused on small-molecule chemical compounds. Biologics require separate patent strategies.
4. How does this patent compete with existing therapeutic patents?
It may cover a novel chemical variation or synthesis method that offers improved efficacy, stability, or safety.
5. What is the importance of patent family filings in international protection?
They extend patent rights internationally, crucial for global commercialization and market exclusivity.
References
[1] U.S. Patent and Trademark Office. (2023). Patent number 11,078,485.
[2] WIPO. (2023). Patent landscape reports on pharmaceutical compounds.
[3] European Patent Office. (2023). Patent filings in chemical therapeutics.
[4] USPTO. (2023). Guidance on patent claim drafting for pharmaceuticals.
[5] patent scope. (2023). Prior art and patent landscape analysis of chemical compounds.
